Among patients with SLE, aPL antibody positive patients are about twice as likely to develop NPSLE than patients who were negative (146) and aPL positivity has been long recognized as a strong risk factor for NPSLE development (147). The gene discussed is FASLG; the disease is systemic lupus erythematosus.